drug · small molecule
patient view →axitinib SR
Marketedupdated 2mo agoby $OCUL OCULAR THERAPEUTIX, INC🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for renal cell carcinoma and neoplasm and 33 investigational indications.
targets
Vascular endothelial growth factor receptor
all catalysts(1)
approval · 1
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that